| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
0.25 － 4 |
Oritavancin (LY333328)  |
207 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
463 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
≤0.5 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
73 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
≤0.5 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
475 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
0.5 － 4 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1056 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
1 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
186 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
374 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
1 － 4 |
Teicoplanin (Targocid) |
178 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
178 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
1 － 8 |
Eperezolid (PNU-100592) |
33 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
2 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1279 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
2 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
109 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
2 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
463 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
≤0.12 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
371 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
0.125 － 8 |
Cefepime (Maxipime) |
113 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
0.125 － 16 |
Cefotaxime (Cephotaxime, Claforan) |
113 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
0.125 － 32 |
Cefoperazone (Cefobid) |
113 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
0.5 － 4 |
Meticillin (Methicillin, Staphcillin) |
178 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
0.5 － >64 |
Cefepime (Maxipime) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 － 4 |
Cefepime (Maxipime) |
1491 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
72 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1060 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 － 8 |
Cefpodoxime |
600 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 － 8 |
Linezolid (PNU-100766, U-100766, Zyvox) |
11 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 － >32 |
Linezolid (PNU-100766, U-100766, Zyvox) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
2 － 4 |
Cefuroxime (Kefurox, Zinacef) |
19 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
2 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
189 |